A detailed history of Mutual Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Mutual Advisors, LLC holds 31,544 shares of NVO stock, worth $2.76 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
31,544
Previous 29,673 6.31%
Holding current value
$2.76 Million
Previous $4.24 Million 11.33%
% of portfolio
0.11%
Previous 0.13%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$119.07 - $145.42 $222,779 - $272,080
1,871 Added 6.31%
31,544 $3.76 Million
Q2 2024

Jul 30, 2024

BUY
$122.71 - $146.91 $292,540 - $350,233
2,384 Added 8.74%
29,673 $4.24 Million
Q1 2024

May 02, 2024

BUY
$102.11 - $135.92 $91,286 - $121,512
894 Added 3.39%
27,289 $3.5 Million
Q4 2023

Jan 12, 2024

BUY
$87.78 - $105.45 $119,644 - $143,728
1,363 Added 5.45%
26,395 $2.73 Million
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $910,855 - $2 Million
10,016 Added 66.7%
25,032 $2.28 Million
Q2 2023

Jul 31, 2023

BUY
$155.98 - $172.65 $216,032 - $239,120
1,385 Added 10.16%
15,016 $2.43 Million
Q1 2023

Apr 11, 2023

SELL
$132.34 - $159.14 $432,619 - $520,228
-3,269 Reduced 19.34%
13,631 $2.17 Million
Q4 2022

Jan 12, 2023

SELL
$102.55 - $135.33 $86,757 - $114,489
-846 Reduced 4.77%
16,900 $0
Q3 2022

Nov 03, 2022

BUY
$95.28 - $116.93 $1.25 Million - $1.53 Million
13,069 Added 279.43%
17,746 $1.77 Million
Q2 2022

Aug 15, 2022

SELL
$103.24 - $121.81 $11,975 - $14,129
-116 Reduced 2.42%
4,677 $521,000
Q1 2022

May 09, 2022

BUY
$93.1 - $112.54 $68,335 - $82,604
734 Added 18.08%
4,793 $532,000
Q4 2021

Feb 14, 2022

BUY
$95.88 - $117.08 $84,086 - $102,679
877 Added 27.56%
4,059 $455,000
Q3 2021

Nov 15, 2021

SELL
$84.42 - $106.62 $40,521 - $51,177
-480 Reduced 13.11%
3,182 $306,000
Q2 2021

Aug 12, 2021

BUY
$67.66 - $84.76 $5,886 - $7,374
87 Added 2.43%
3,662 $307,000
Q1 2021

May 13, 2021

SELL
$67.06 - $75.82 $785,473 - $888,079
-11,713 Reduced 76.62%
3,575 $241,000
Q4 2020

Feb 11, 2021

SELL
$63.89 - $73.8 $267,379 - $308,853
-4,185 Reduced 21.49%
15,288 $1.07 Million
Q3 2020

Nov 13, 2020

SELL
$63.69 - $70.22 $45,156 - $49,785
-709 Reduced 3.51%
19,473 $1.35 Million
Q2 2020

Aug 05, 2020

BUY
$58.54 - $67.94 $864,460 - $1 Million
14,767 Added 272.71%
20,182 $1.32 Million
Q1 2020

May 13, 2020

BUY
$49.46 - $64.78 $12,909 - $16,907
261 Added 5.06%
5,415 $326,000
Q4 2019

Feb 11, 2020

BUY
$49.86 - $58.26 $24,979 - $29,188
501 Added 10.77%
5,154 $298,000
Q3 2019

Nov 01, 2019

BUY
$47.54 - $53.43 $221,203 - $248,609
4,653 New
4,653 $241,000
Q1 2019

May 15, 2019

SELL
$46.36 - $52.63 $296,704 - $336,832
-6,400 Closed
0 $0
Q4 2018

Feb 15, 2019

BUY
$41.54 - $47.25 $265,856 - $302,400
6,400 New
6,400 $295,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Mutual Advisors, LLC Portfolio

Follow Mutual Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mutual Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mutual Advisors, LLC with notifications on news.